Duke University made a claim on the estate of oil magnate Aubrey McClendon, saying the Chesapeake Energy co-founder died before he could make good on roughly $10 million of pledges.
While Delta and other airlines improve how they track luggage, new products like Trakdot, LugLoc and the Bluesmart bag let you track your own, Scott McCartney writes.
Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.
Commodities giant Glencore reported a narrower first-half net loss and signaled that it is on track to reduce debt by selling unwanted assets.
Company’s printing-supplies unit sees its worst decline so far and isn’t expected to stabilize until next year.
Sales of previously owned homes slipped 3.2% in July, a sign the U.S. housing-market recovery could be uneven as limited inventory and rising prices put purchases out of reach for some Americans.
Some of the world’s largest energy companies are saddled with their highest debt levels ever as they struggle with low crude prices, raising worries about their ability to pay dividends and find new barrels.
Paramount Chief Executive Brad Grey and his team are under pressure from the Viacom board to defend their film record and present a turnaround plan.
Pfizer said the deal would boost its stable of older products, some of which have lost patent protection.
Cnooc’s low level of overall oil reserves means it will have to undo cost costs at some point.